This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
San Diego-based venture capital firm EnterprisePartners is one of the firms in a $39M, Series E funding round for Mountain View-based Complete Genomics , Complete Genomics said today. Complete Genomics is developing a DNA sequencing product which competes against products from Illumina.
Vista-based Opthonix , a developer of wavefront guided, high definition vision eyeglasses, has raised $5.39M as part of an ongoing, $12.1M Opthonix is venture backed by Cross Creek Capital, DAG Ventures, EnterprisePartners, Gund Investment Corp., Details on the funding have not been announced by the company.
San Diego-based ecoATM , a developer of automated kiosks for recycling cell phones and other electronics, said this morning that it has raised a first institutional round of funding. The round came from TAO Venture Partners, the new venture firm run by Tom Clancy. Clancy was previously managing director at EnterprisePartners.
San Diego-based TargeGen , a firm developing small molecule kinase inhibitors for the treatment of myelofibrosis (MF) and polycythemia vera (PV), has been acquired by Sanofi-aventis, in a deal worth as much as $560M, the firm said Wednesday. The firm was advised by Peter J. Solomon Company in the deal.
San Diego-based XIFIN , a developer of cloud-based software for the healthcare diagnostics market, has been acquired by private equity investor GTCR. GTCR said the investment came from its $3.85 XIFIN''s backers include Boulder Ventures, EnterprisePartners, and Windward Ventures. READ MORE>>.
La Jolla-based Celladon Corporation , a developer of biopharmaceuticals targeting cardiovascular disease, said Wednesday afternoon that it has raised $43M in a financing round. Celladon is developing a compound for treating heart failure.
The information--gleaned from funding announcements, regulatory filings, and other sources--are not far off from socalTECH's totals from last quarter, which totaled up around $932M in investment activity. San Diego led investment activity in Q3, with a large number of the biggest VC deals all located in the area.
San Diego- and Baltimore-based private equity investor JMI Equity is the lead backer of a developer of artificial intelligence software for the healthcare industry this morning. The funding was led by JMI Equity, and also included Health EnterprisePartners (HEP) and Health Velocity Capital (HVC). READ MORE>>.
San Diego-based Scoperta , which is developing fabless specialty steel technology utilizing scrap materials, has raised $1.4M Other details on the funding have not been released, however, the firm is backed by EnterprisePartners and Vista Ventures, and Drew Senyei of Enterprise sits on the firm's board of directors.
Vista-based Ophthonix , which is developing high definition vision correction products, announced Tuesday afternoon that it has raised $25.9M Ophthonix develops the iZon lens system, which uses mapping of a person's visual aberrations to customize their eyeglass lenses for better visual acuity.
It''s the same as a software company, which might take a lot of time and investment to develop a software program, and then license it on a per-seat basis to their enterprisepartners. As such, they pay us an upfront fee of $40,000 per store, and they pay us a half a percent royalty on gross sales.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content